Back to AZNView Full Landscape
Phase 3
Development Phase
0
Upcoming Catalysts
1
Historical Events
0
Regulatory Approvals
Competitive Landscape
12 competitors in Non-Small Cell Lung Cancer
REGNLibtayo
Phase 3MRKArm A: Pemetrexed Cisplatin
Phase 2SNYoxaliplatine / gemcitabine / Vinorelbine
Phase 2RHHBYerlotinib HCl
Phase 2BNTXBNT327
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts